Open AccessA single, low dose of a current Good Manufacturing Practice (cGMP) recombinant BCG vaccine confers protection against human respiratory syncytial virus (hRSV) infection and lung pathology in mice
Author(s) -
Céspedes Pablo,
Palavecino Christian,
Rivera Claudia,
Kalergis Alexis,
Bueno Susan
Publication year - 2015
Publication title -
frontiers in immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.646
H-Index - 124
ISSN - 1664-3224
DOI - 10.3389/conf.fimmu.2015.05.00182
Subject(s) - virology , bronchiolitis , virus , medicine , vaccination , pneumovirus , recombinant dna , pneumonia , immunology , outbreak , human parainfluenza virus , paramyxoviridae , biology , viral disease , biochemistry , gene